Bone marrow transplantation for therapy-related acute myeloid leukemia in congenital retinoblastoma associated with 13q deletion syndrome

Annals of Hematology

Volumn 83, Issue 7, 2004, Pages 481-483

  Hon, C ^a   Chan, G C F ^a   Ha, S Y ^a   Ma, S K ^a   Wong, K F ^b   Au, W Y ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b Queen Elizabeth Hopsital ^*  (China)

Author keywords

AML; Deletion 13q; Marrow transplantation; Retinoblastoma

Indexed keywords

CARBOPLATIN; CYCLOSPORIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; METHOTREXATE; RETINOBLASTOMA PROTEIN; TENIPOSIDE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CASE REPORT; CHROMOSOME 13Q; CHROMOSOME DELETION; CRYOTHERAPY; DISEASE ACTIVITY; FEMALE; GENE LOSS; GRAFT VERSUS HOST REACTION; HUMAN; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA; RISK ASSESSMENT; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ACUTE DISEASE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CRYOSURGERY; CRYOTHERAPY; CYCLOSPORINE; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EYE NEOPLASMS; FEMALE; HUMANS; INFANT, NEWBORN; LEUKEMIA, MYELOID; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROTO-ONCOGENES; REMISSION INDUCTION; RETINOBLASTOMA; TENIPOSIDE; TRANSCRIPTION FACTORS; VINCRISTINE;

EID: 3042771623     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-004-0884-5     Document Type: Article

References (24)

1. Schouten-Van Meeteren AY, Moll AC, Imhof SM, Veerman AJ (2002) Overview: chemotherapy for retinoblastoma: an expanding area of clinical research. Med Pediatr Oncol 38:428-438
2. Moll AC, Imhof SM, Schouten-Van Meeteren AY, Kuik D J, Hofman P, Boers M (2001) Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk? Ophthalmology 108:1109-1114
3. Moll AC, Imhof SM, Bouter LM, Kuik DJ, Den Otter W, Bezemer PD et al (1996) Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer 67:515-519
4. Saito T, Kaneko A, Muramatsu Y, Inomata M, Murakami Y, Den S et al (1998) Difficult tracheal intubation in patients with retinoblastoma caused by 13q deficiency. Jpn J Clin Oncol 28:507-510
5. Ganesh A, Kenue RK, Mitra S (2001) Retinoblastoma and the 13q deletion syndrome. J Pediatr Ophthalmol Strabismus 38:247-250
6. Pratt CB, Fontanesi J, Lu X, Parham DM, Elfervig J, Meyer D (1997) Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist 2:1-5
7. Chan HS, DeBoer G, Thiessen JJ, Budning A, Kingston JE, O'Brien JM et al (1996) Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res 2:1499-1508
8. Kwong YL, Tso SC, Wong KF, Tang KC, Chan TK (1995) Translocational rearrangements of 11q23 in acute monoblastic leukemia. Cancer Genet Cytogenet 82:76-79
9. Kwong YL, Wong KF (1997) Acute myeloid leukemia with trisomy 11: a molecular cytogenetic study. Cancer Genet Cytogenet 99:19-23
10. Kornblau SM, Xu HJ, Zhang W, Hu SX, Beran M, Smith TL et al (1994) Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 84:256-261
11. Jamal R, Gale RE, Shaun N, Thomas B, Wheatley K, Linch DC (1996) The retinoblastoma gene (rb1) in acute myeloid leukaemia: analysis of gene rearrangements, protein expression and comparison of disease outcome. Br J Haematol 94:342-351
12. Barbosa de Melo M, Costa FF, Saad ST, Lorand-Metze I, Bordin S, Ahmad NN (1998) Molecular analysis of the retinoblastoma (RB1) gene in acute myeloid leukemia patients. Leuk Res 22:787-792
13. Kornblau SM, Qiu YH (1999) Altered expression of retinoblastoma (RB) protein in acute myelogenous leukemia does not result from methylation of the Rb promotor. Leuk Lymphoma 35:283-288
14. Gallegos-Castorena S, Medina-Sanson A, Gonzalez-Montalvo P, Martinez-Avalos A, Zafra de la Rosa GZ (2002) Acute myeloid leukemia in a patient surviving retinoblastoma (letter to the editor). Med Pediatr Oncol 38:450
15. Nishimura S, Sato T, Ueda H, Ueda K (2001) Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma. J Clin Oncol 19:4182-4183
16. Felice MS, Zubizarreta PA, Chantada GL, Alfaro E, Cygler AM, Gallego M et al (1998) Acute myeloid leukemia as a second malignancy: report of 9 pediatric patients in a single institution in Argentina. Med Pediatr Oncol 30:160-164
17. Turner AR, Melynk A, Clark G (1996) MDS and acute monocytic leukaemia after retinoblastoma. Br J Haematol 92:249
18. Morris CM, Cochrane JM, Benjes SM, Crossen PE, Fitzgerald PH (1991) Molecular definition of interstitial deletions of chromosome 13 in leukemic cells. Genes Chromosomes Cancer 3:455-460
19. Coignet LJ, Lima CS, Min T, Streubel B, Swansbury J, Telford N et al (1999) Myeloid- and lymphoid-specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia. Genes Chromosomes Cancer 25:222-229
20. Stefanova M, Dierlamm J, Michaux L, Leberecht P, Seeger D, Hinz K et al (2000) Polysomy 13 with concomitant deletion of 13q13-14 involving the retinoblastoma gene and the D13S25 locus in a case of acute myeloid leukemia. Cancer Genet Cytogenet 119:158-161
21. Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B et al (1999) Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17:569-577
22. Saleh RA, Gross S, Cassano W, Gee A (1988) Metastatic retinoblastoma successfully treated with immunomagnetic purged autologous bone marrow transplantation. Cancer 62:2301-2303
23. Sasabe T, Kiritoshi A, Ohashi Y, Manabe R (1987) Interferon enhances the natural killer cell activity of the retinoblastoma patients to autologous retinoblastoma cells. Ophthalmic Paediatr Genet 8:43-46
24. Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF (2001) Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 119:1269-1272